otcbargains undervalued stock board

[StockDetective]

$ARYC Silicon Valley biotech stock Arrayit Corporation.

Due Diligence link:

https://cdn.discordapp.com/attachments/357369664193560596/459932549062590475/Arrayit_Due_Diligence_Report_.pdf


ARYC chart:
http://stockcharts.com/h-sc/ui?s=Aryc


Recent Press Release:

Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
Print
Alert
Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has completed an allergy testing pilot program for one of nation’s largest chains of retail stores. The retailer collected finger stick blood specimens from 126 customers at their in-store clinics, and shipped the blood cards to Arrayit for processing. Arrayit processed the specimens and reported 126 quantitative total immunoglobulin E (IgE) measurements and 15,120 allergen-specific determinations indicative of food and environmental allergies. The test results were reviewed and approved by the retail chain’s Chief Medical Officer.

Arrayit allergy testing is particularly suitable for large retail chains because convenient finger stick sampling allows customers to integrate a physician-ordered allergy test into their real-time shopping experience. The test results, together with patient symptoms and medical history, enable in-store doctors to make personalized medical recommendations about allergy and asthma treatments and medicines, which are also conveniently provided by the retailer. The retail chain, which reports revenues exceeding $50,000,000,000 ($50 billion US dollars) annually, has more than 2,000 locations nationwide.

Arrayit CEO Rene Schena states, “Completing an allergy testing pilot program for a major retailer advances our clinical initiatives. Arrayit personalized allergy testing, in the context of 1,700 sales reps and a large retail chain, would accelerate our mission to provide health and wellness information to millions of American households.”

https://www.yahoo.com/amphtml/finance/news/arrayit-corporation-completes-allergy-testing-093000485.html


Recent company Tweets:

Arrayit signs capital financing agreement with a top buy-side analyst at a leading corporate intelligence firm headquartered in London UK with offices in New York and providing buy-side intelligence to high net worth retail investors, institutional investors and hedge funds.

Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.

Arrayit senior management receives NASDAQ and NYSE up-listing proposal from small and mid-cap consulting experts http://uplisting.com focusing on growth companies seeking to improve and enhance shareholder value by listing on a major stock exchange http://www.uplisting.com

Arrayit senior management receives Industry Innovators television interview invitation hosted by elite business and affluent consumer leaders Talk Business 360 airing July 28 2018 on Fox Business Network and available to 80+ million viewers nationwide (link: http://talkbusiness360.com) talkbusiness360.com

Arrayit senior management receives Industry Innovators television interview invitation hosted by elite business and affluent consumer leaders Talk Business 360 airing July 28 2018 on Fox Business Network and available to 80+ million viewers nationwide https://t.co/VL77SGOdO9 pic.twitter.com/fy4efcEvFV

— Arrayit Corporation (@arrayit) July 10, 2018

Arrayit Corporation (ARYC) CEO Rene Schena will provide a letter to shareholders as soon as the company resumes current financial reporting (summer of 2018).

http://arrayit.com/Microarray_Investor/Arrayit_Letter_to_Shareholders/arrayit_letter_to_shareholders_from_the_ceo.html


Arrayit Corporation (ARYC) complies with federal rules and regulations governing public companies, including making disclosures with the United States Securities and Exchange Commission (SEC). We will resume quarterly and annual financial filings during the summer of 2018. Please consult ARYC data at sec.gov for our current and past filings.

http://arrayit.com/Microarray_Investor/ARYC_SEC_Filings/aryc_sec_filings.html